Literature DB >> 19802341

Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.

Alan Daugherty1, Hong Lu, Debra L Rateri, Lisa A Cassis.   

Abstract

Activation of the renin-angiotensin system (RAS) and aberrant cholesterol metabolism have generally been considered as independent mechanisms in the development of several vascular diseases. However, it is becoming increasingly apparent in both human and animal studies that many aspects of the RAS may be augmented by hypercholesterolemia, resulting in enhancement of the severity and occurrence of several vascular diseases, including hypertension, atherosclerosis and abdominal aortic aneurysms. Some potential hypercholesterolemia-induced mechanisms have been demonstrated to increase activity of specific components of the RAS. These include increased AT1-receptor expression, increased responsiveness to Ang II and increased synthesis of angiotensin peptides. Future studies need to validate mechanisms of hypercholesterolemia-induced RAS activation in different vascular diseases.

Entities:  

Year:  2008        PMID: 19802341      PMCID: PMC2636897          DOI: 10.2217/17460875.3.6.625

Source DB:  PubMed          Journal:  Future Lipidol        ISSN: 1746-0875


  100 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

Review 3.  Statins and blood pressure regulation.

Authors:  C Borghi; M Veronesi; M G Prandin; A Dormi; E Ambrosioni
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

4.  Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

Authors:  Daniel G Hackam; Deva Thiruchelvam; Donald A Redelmeier
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

5.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

6.  Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

Authors:  G Nickenig; A Sachinidis; F Michaelsen; M Böhm; S Seewald; H Vetter
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

7.  Inhibited aortic aneurysm formation in BLT1-deficient mice.

Authors:  Neil Ahluwalia; Alexander Y Lin; Andrew M Tager; Ivy E Pruitt; Thomas J T Anderson; Fjoralba Kristo; Dongxiao Shen; Anna R Cruz; Masanori Aikawa; Andrew D Luster; Robert E Gerszten
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.

Authors:  Tracy Henriques; Xuan Zhang; Frederique B Yiannikouris; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

9.  Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats.

Authors:  Lisa A Cassis; Jing Huang; Ming C Gong; Alan Daugherty
Journal:  Regul Pept       Date:  2004-02-15

Review 10.  Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease.

Authors:  Michael W Manning; Lisa A Cassi; Jing Huang; Stephen J Szilvassy; Alan Daugherty
Journal:  Vasc Med       Date:  2002-02       Impact factor: 3.239

View more
  7 in total

1.  Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice.

Authors:  Tao Tang; Patricia G Wilson; Joel C Thompson; Christina Nelson; Meghan H Yoder; Lisa R Tannock
Journal:  J Lipid Res       Date:  2013-06-07       Impact factor: 5.922

Review 2.  Genetic variants of the Renin Angiotensin system: effects on atherosclerosis in experimental models and humans.

Authors:  Alan Daugherty; Aruna Poduri; Xiaofeng Chen; Hong Lu; Lisa A Cassis
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

3.  Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.

Authors:  Xiaofeng Chen; Hong Lu; Mingming Zhao; Katsuya Tashiro; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-11       Impact factor: 8.311

4.  N-3 PUFAs protect against aortic inflammation and oxidative stress in angiotensin II-infused apolipoprotein E-/- mice.

Authors:  Kathryn M Wales; Kristyn Kavazos; Maria Nataatmadja; Peter R Brooks; Chloe Williams; Fraser D Russell
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Monosomy X in Female Mice Influences the Regional Formation and Augments the Severity of Angiotensin II-Induced Aortopathies.

Authors:  Yasir AlSiraj; Sean E Thatcher; Eric Blalock; Wesley N Saintilnord; Alan Daugherty; Hong S Lu; Wei Luo; Ying H Shen; Scott A LeMaire; Arthur P Arnold; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

6.  Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.

Authors:  Xiaofeng Chen; Debra L Rateri; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Andrew J Morris; Richard Charnigo; Lisa A Cassis; Alan Daugherty
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

Review 7.  Structure and functions of angiotensinogen.

Authors:  Hong Lu; Lisa A Cassis; Craig W Vander Kooi; Alan Daugherty
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.